AKT1 and cancer: As the membrane composition of cancer cells and neurons differs, we do not exclude the possibility of another mechanism through which plasmalogens promote the Akt pathway and cancer cell growth, including other pathways involved in Figure 5A. For example, ether lipids have been shown to scavenge ROS 81-83, which might help cancer cells to evade ROS-induced damage.